Log in
Register|
vish14184 ★ India, 2007-07-06 15:34 (6931 d 10:51 ago) Posting: # 867 Views: 4,706 |
|
|
Dear all. please give me information about how to design replicate study? please give me referense of this type of study. thanks in advanse With regards vishal nakrani |
|
H_Rotter ★ Germany, 2007-07-06 17:38 (6931 d 08:47 ago) @ vish14184 Posting: # 868 Views: 3,834 |
|
|
Dear Vishal, have a look at this thread. Further information at Helmut's News Collection on Highly Variable Drugs: http://bebac.at/news/2006-04-27.htm http://bebac.at/news/2006-10-06.htm Hermann |
|
shankar ★ India, 2007-07-11 08:13 (6926 d 18:12 ago) (edited on 2007-07-11 10:40) @ vish14184 Posting: # 875 Views: 3,679 |
|
|
Dear vishal, Replicate study designs are recommended for BE studies of modified-release dosage forms and highly variable drug products (within-subject coefficient of variation ≥30%), including those that are immediate release, modified-release, and other orally administered drug products. Please refer attached link of FDA guidelines. Regards, Shankar NJ I edited your post removing UTF-16 (2 Byte Unicodes) from the text. Please use the before posting. [HS] Edit: Link corrected for FDA’s new site. [Helmut] |
|
Helmut ★★★   Vienna, Austria, 2007-07-11 15:22 (6926 d 11:03 ago) @ shankar Posting: # 882 Views: 3,764 |
|
|
Dear Shankar! ❝ Replicate study designs are recommended for BE studies of modified-release dosage forms […] Do you have any current reference supporting this claim of yours? — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png) Helmut Schütz ![[image]](https://static.bebac.at/img/CC by.png) The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
Ing. Helmut Schütz